BLEVF - Beleave Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0831
-0.0020 (-2.32%)
At close: 3:43PM EST
Stock chart is not supported by your current browser
Previous Close0.0851
Open0.0860
Bid0.000000 x 0
Ask0.000000 x 0
Day's Range0.0823 - 0.0860
52 Week Range0.0500 - 1.7281
Volume222,200
Avg. Volume376,380
Market Cap38.912M
Beta (3Y Monthly)3.82
PE Ratio (TTM)N/A
EPS (TTM)-0.074000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group5 days ago

    Beleave Announces Board and Management Refresh

    James (Jim) Wasserstrom : A native of New York , Jim has extensive international experience and expertise in governance, compliance and internal control. Jim spent the early part of his career in various corporate capacities, including as a global partnerships executive for American Express Travel Related Services.  In 2002, Jim led the United Nations operation overseeing Kosovo's public utilities representing $4 billion in assets transforming many into modern and profitable businesses.  From 2009-2014, Mr. Wasserstrom led the US effort to combat corruption for the United States Government in Afghanistan , engaging extensively with the military, and international organizations and governments.

  • PR Newswire12 days ago

    Medi-Green Invites the Community to Grand Opening of its New Clinic in London, Ontario

    TORONTO, Feb. 12, 2019 /PRNewswire/ - Medi-Green, a wholly-owned subsidiary of Beleave (BE.CN) (BLEVF) ("Beleave" or the "Company") is excited to invite the community to the grand opening event of its new clinic in London, Ontario this Friday, February 15, 2019. "We are very excited to expand our Medi-Green family into the London region and continue to provide a comforting and encouraging environment for patients seeking medical cannabis as a form of treatment," said Ashleigh Koeslag, Operations Manager. During the event, staff from Medi-Green will be present to answer questions and share information about cannabis and the clinic's services with attendees.

  • CNW Group24 days ago

    Beleave Awarded ISO 9001:2015 Certification as Part of Ongoing Commitment to Improve Efficiency

    TORONTO , Jan. 31, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corporation, has obtained ISO 9001:2015 Certification for the research, development, and production of cannabis products for medicinal and recreational purposes at its Hamilton, Ontario facility. ISO 9001 is a quality management system standard developed by the International Organization for Standardization, an association of governmental and nongovernmental organizations from many countries. ISO 9001:2015 is the most up-to-date standard of its kind and contains key updates, including an emphasis on risk-based thinking to enhance the application of the process approach, improved applicability for services, and increased leadership requirements.

  • PR Newswirelast month

    Beleave Provides an Update on the BCSC's Temporary Order

    TORONTO, Jan. 17, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its participation and cooperation regarding the ongoing investigation by the British Colombia Securities Commission ("BCSC"). As previously announced, Beleave was named as a respondent in a temporary order dated November 26, 2018 (the "Temporary Order") issued by the Executive Director of the BCSC in connection with distributions to certain individuals connected to the "BridgeMark Group". The Executive Director of the BCSC sought an extension of the Temporary Order (the "Extension Request") pending the conclusion of the BCSC's investigation into the Respondents' reliance on the Consultant Exemption.

  • CNW Grouplast month

    Beleave Announces Executive Management Developments and Provides Activity Updates

    TORONTO , Jan. 16, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that Bill Panagiotakopoulos , current COO at Beleave, has been appointed by the Board of Directors to act as the Executive Chairman to further strengthen Beleave's governance and oversight controls. As one of the Company's founding members in 2011, Bill was an early mover in Canada's cannabis sector. Since then, Bill has been significantly involved in the successful navigation of the regulatory framework to obtain cannabis production and sales licenses.

  • PR Newswirelast month

    Beleave Receives Health Canada Authorization to Sell Cannabis Oils

    TORONTO, Jan. 15, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is excited to announce its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations. "This license is pivotal to us meeting our goals in 2019, while driving product innovation and augmenting our research and development initiatives," said Roger Ferreira, Ph.D., Beleave's Chief Science Officer.

  • CNW Group2 months ago

    Beleave Provides Update and Clarification on GMP Certification Process

    TORONTO , Dec. 17, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update and clarification on the Company's GMP certification process. As part of the process, Global Compliance Inc. has inspected and assessed the Company's processes for the production of medical and recreational cannabis and determined that the facility meets all requirements for certification. Beleave is seeking GMP certification so the Company can export medical cannabis to its German partner, Canymed GmbH, and expects to be audited by the German GMP certification authority early next year.

  • PR Newswire2 months ago

    CORRECTION - Beleave Announces GMP Certification and Operational Updates

    Please note that the below is a corrected version of the news release previously disseminated December 13th at 5pm. Beleave Inc. has advised that changes were made to the third and fourth paragraphs. TORONTO, Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use.

  • CNW Group2 months ago

    Beleave Announces GMP Certification and Operational Updates

    TORONTO , Dec. 13, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use. This certification solidifies the practices the Company has been perfecting in relation to product development and it demonstrates our commitment to food safety and hygiene.

  • CNW Group3 months ago

    Beleave Announces Second Quarter of 2018 Results

    TORONTO , Nov. 29, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces today the release of its Interim Condensed Consolidated Financial Statements for the second quarter ended September 30, 2018 , together with its Management, Discussion and Analysis ("MD&A"). All values in this news release and the Company's financial disclosures are in Canadian dollars unless otherwise stated. The Company had revenues of $315,617 that didn't include recreational sales that began in October, however it was an improvement over last quarter's revenues of $208,617 .

  • CNW Group3 months ago

    /R E P E A T -- Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call/

    TORONTO , Nov. 23, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time) . The call will be hosted by Andrew T. Wnek , Chairman and CEO, Bojan Krasic , President and CFO and select members of the senior management team. The November corporate presentation will be available on the Company's website prior to the call, which can be accessed at www.beleave.com.

  • CNW Group3 months ago

    Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call

    TORONTO , Nov. 23, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time) . The November corporate presentation will be available on the Company's website prior to the call, which can be accessed at www.beleave.com.

  • CNW Group3 months ago

    Beleave Announces Development of Cannabis-Infused Powder and Sugar Products for the Recreational Market

    TORONTO , Nov. 15, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year. Beleave's Hamilton laboratory is being expanded to make room for methods to formulate cannabis extracts into soluble, flavourless powders, sugar crystals, and syrups for use in beverages and food products using stability-enhancing techniques for prolonged shelf-life. The final product offered to consumers will be a flexible, food-grade ingredient that delivers an accurate dose of THC and CBD when ingested orally, and with enhanced bioavailability.